CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $70,369,463
- in 12 filings, $45.5M under 10b5-1 plans
Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-16 | Gold Daniel Allen Director | Grant or award | +5,054 | 8,965,815 | ||
| 2026-09-16 | Gold Daniel Allen Director | Grant or award · Stock Option (Right to Buy) | +10,531 | 10,531 | ||
| 2026-09-10 | Gold Daniel Allen Director | Shares withheld for taxes | −5,133 | $40.94 | $210K | 8,960,761 |
| 2026-06-30 | Gold Daniel Allen Director | Sale | −12,380 | $35.28 | $437K | 13,689,166 |
| 2026-06-29 | Gold Daniel Allen Director | Sale | −200,000 | $34.44 | $6.9M | 14,301,546 |
| 2026-06-29 | Gold Daniel Allen Director | Sale | −600,000 | $34.59 | $20.8M | 13,701,546 |
| 2026-06-26 | Gold Daniel Allen Director | Sale | −300,783 | $33.92 | $10.2M | 14,826,546 |
| 2026-06-26 | Gold Daniel Allen Director | Sale | −325,000 | $34.07 | $11.1M | 14,501,546 |
| 2026-02-13 | Gold Daniel Allen Director | Sale | −150,784 | $26.49 | $4.0M | 15,352,329 |
| 2026-02-13 | Gold Daniel Allen Director | Sale | −225,000 | $26.50 | $6.0M | 15,127,329 |
| 2026-02-12 | Gold Daniel Allen Director | Sale | −150,000 | $26.72 | $4.0M | 15,778,113 |
| 2026-02-12 | Gold Daniel Allen Director | Sale | −275,000 | $26.76 | $7.4M | 15,503,113 |
| 2026-02-11 | Gold Daniel Allen Director | Sale | −425,000 | $26.67 | $11.3M | 15,928,113 |
| 2025-12-17 | Gold Daniel Allen Director | Sale | −432,718 | $23.05 | $10.0M | 16,697,727 |
| 2025-12-17 | Gold Daniel Allen Director | Sale | −155,076 | $23.02 | $3.6M | 16,542,651 |
| 2025-12-17 | Gold Daniel Allen Director | Sale | −189,538 | $23.17 | $4.4M | 16,353,113 |
| 2025-12-16 | Gold Daniel Allen Director | Sale | −275,000 | $22.93 | $6.3M | 17,772,727 |
| 2025-12-16 | Gold Daniel Allen Director | Sale | −642,282 | $23.08 | $14.8M | 17,130,445 |
| 2025-11-19 | Gold Daniel Allen Director | Sale | −850,000 | $20.25 | $17.2M | 18,497,727 |
| 2025-11-19 | Gold Daniel Allen Director | Sale | −150,000 | $20.20 | $3.0M | 18,347,727 |
Page 1 of 3 · 52 trades